Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
FEBRILE CHILDREN WITH COMORBIDITIES AT THE EMERGENCY DEPARTMENT - A MULTICENTRE OBSERVATIONAL STUDY
Borensztajn DM, Hagedoorn NN, Carrol ED, von Both U, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Tsolia M, van der Velden FJS, Vermont C, Zavadska D, Zenz W, Zachariasse JM, Moll HA
Journal:
Eur J Pediatr
Publicación independiente
Impact factor
3.860
Q1
RSV PREVENTION IN ALL INFANTS: WHICH IS THE MOST PREFERABLE STRATEGY?
Esposito S, Abu Raya B, Baraldi E, Flanagan K, Martinon Torres F, Tsolia M, Zielen S
Journal:
Front Immunol
Publicación independiente
Impact factor
8.876
Q1
RISK ANALYSIS BY AGE ON THE BURDEN OF MENINGOCOCCAL DISEASE IN SPAIN
Rivero-Calle I, Raguindin PF, Pardo-Seco J, Martinon-Torres F
Journal:
Vaccines
Publicación independiente
Impact factor
4.961
Q2
MENINGOCOCCAL B VACCINE EFFECTIVENESS
Banzhoff A, Martinón-Torres F
Journal:
J Pediatr
Publicación independiente
Impact factor
6.314
Q1
GLOBAL, REGIONAL, AND NATIONAL DISEASE BURDEN ESTIMATES OF ACUTE LOWER RESPIRATORY INFECTIONS DUE TO RESPIRATORY SYNCYTIAL VIRUS IN CHILDREN YOUNGER THAN 5 YEARS IN 2019: A SYSTEMATIC ANALYSIS
Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H, Pariente AB, Bardach D, Bassat Q, Casalegno JS, Chakhunashvili G, Crawford N, Danilenko D, Do LAH, Echavarria M, Gentile A, Gordon A, Heikkinen T, Huang QS, Jullien S, Krishnan A, Lopez EL, Markić J, Mira-Iglesias A, Moore HC, Moyes J, Mwananyanda L, Nokes DJ, Noordeen F, Obodai E, Palani N, Romero C, Salimi V, Satav A, Seo E, Shchomak Z, Singleton R, Stolyarov K, Stoszek SK, von Gottberg A, Wurzel D, Yoshida LM, Yung CF, Zar HJ; Respiratory Virus Global Epidemiology Network, Nair H; RESCEU investigators (Martinón-Torres F)
Journal:
Lancet
Publicación independiente
Impact factor
202.710
Q1
Year:
2022
Doi:
¿Dónde se esconde el virus respiratorio sincitial?
Martinón-Torres F, González-Barcala FJ
Journal:
Arch Bronconeumol
Publicación independiente
Impact factor
6.333
Q1
A TOOL FOR EARLY ESTIMATION OF INFLUENZA VACCINATION COVERAGE IN SPANISH GENERAL POPULATION AND HEALTHCARE WORKERS IN THE 2018-19 SEASON: THE GRIPÓMETRO
Díez-Domingo J, Redondo Margüello E, Ortiz de Lejarazu Leonardo R, Gil de Miguel Á, Guillén Ortega JM, Rincón Mora J, Martinón-Torres F
Journal:
BMC Public Health
Publicación independiente
Impact factor
4.135
Q2
WHOOPING COUGH: THE VISIBLE ENEMY
González-Barcala FJ, Villar-Álvarez F, Martinón-Torres F
Journal:
Arch Bronconeumol
Publicación independiente
Impact factor
6.333
Q1
ROLE AND DIAGNOSTIC PERFORMANCE OF HOST EPIGENOME IN RESPIRATORY MORBIDITY AFTER RSV INFECTION: THE EPIRESVI STUDY.
Pischedda S, Rivero-Calle I, Gómez-Carballa A, Cebey-López M, Barral-Arca R, Gómez-Rial J, Pardo-Seco J, Curras-Tuala MJ, Viz-Lasheras S, Bello X, Crujeiras AB, Diaz-Lagares A, González-López MT, Martinón-Torres F, Salas A; GENDRES consortium
Journal:
Front Immunol
Publicación independiente
Impact factor
8.786
Q1
EVALUATION OF BNT162B2 VACCINE EFFECTIVENESS IN GALICIA, NORTHWEST SPAIN
Pardo-Seco J, Mallah N, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, Durán-Parrondo C, Rodríguez-Tenreiro C, Rivero-Calle I, Gómez-Carballa A, Salas A, Martinón-Torres F
Journal:
Int J Environ Res Public Health
Publicación independiente
Impact factor
3.390
Q2
¿Dónde se esconde el virus respiratorio sincitial?
Martinón-Torres F, González-Barcala FJ
Journal:
Arch Bronconeumol
Publicación independiente
Impact factor
4.872
Q2
YEAR-TO-YEAR VARIATION IN ATTACK RATES COULD RESULT IN UNDERPOWERED RESPIRATORY SYNCYTIAL VIRUS VACCINE EFFICACY TRIALS
Billard MN, Wildenbeest J, Bont LJ, Nair H, McCracken JP, Oude Rengerink K; RESCEU Investigators (Martinón-Torres F)
Journal:
J Clin Epidemiol
Publicación independiente
Impact factor
6.437
Q1
Year:
2022
Doi:
COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE PREVENTION STRATEGIES: MATERNAL VACCINE VERSUS SEASONAL OR YEAR-ROUND MONOCLONAL ANTIBODY PROGRAM IN NORWEGIAN CHILDREN
Li X, Bilcke J, Vázquez Fernández L, Bont L, Willem L, Wisløff T, Jit M, Beutels P; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators. (martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.226
Q1
Year:
2022
Doi:
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II TRIAL TO EXPLORE THE EFFECTS OF A GABAA-Α5 NAM (BASMISANIL) ON INTELLECTUAL DISABILITY ASSOCIATED WITH DOWN SYNDROME
Goeldner C, Kishnani PS, Skotko BG, Casero JL, Hipp JF, Derks M, Hernandez MC, Khwaja O, Lennon-Chrimes S, Noeldeke J, Pellicer S, Squassante L, Visootsak J, Wandel C, Fontoura P, d'Ardhuy XL; Clematis Study Group (Martinón-Torres F)
Journal:
J Neurodev Disord
Publicación independiente
Impact factor
4.025
Q2
Year:
2022
Doi:
PERFORMANCE ASSESSMENT OF A RAPID MOLECULAR RESPIRATORY SYNCYTIAL VIRUS POINT-OF-CARE TEST: A PROSPECTIVE COMMUNITY STUDY IN OLDER ADULTS
Zuurbier RP, Korsten K, Verheij TJM, Butler C, Adriaenssens N, Coenen S, Gruselle O, Vantomme V, van Houten MA, Bont LJ, Wildenbeest JG; REspiratory Syncytial Virus Consortium in EUrope (RESCEU) Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.226
Q1
Year:
2022
Doi:
RAPID VIRAL TESTING AND ANTIBIOTIC PRESCRIPTION IN FEBRILE CHILDREN WITH RESPIRATORY SYMPTOMS VISITING EMERGENCY DEPARTMENTS IN EUROPE
Tan CD, Hagedoorn NN, Dewez JE, Borensztajn DM, von Both U, Carrol ED, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Strle F, Tsolia M, Vermont CL, Yeung S, Zachariasse JM, Zenz W, Zavadska D, Moll HA; PERFORM Consortium
Journal:
Pediatr Infect Dis J
Publicación independiente
Impact factor
2.129
Q4
Pediatric vaccination against COVID-19 and despite COVID-19
Martinón-Torres F
Journal:
An Pediatr (Engl Ed)
Publicación independiente
Impact factor
1.500
Q4
A SYSTEMATIC REVIEW OF EUROPEAN CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS
Reeves RM, van Wijhe M, Lehtonen T, Stona L, Teirlinck AC, Vazquez Fernandez L, Li Y, Osei-Yeboah R, Fischer TK, Heikkinen T, van Boven M, Bøås H, Donà D, Barbieri E, Campbell H; RESCEU Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2022
Doi:
EQUITY IN VACCINATION POLICIES TO OVERCOME SOCIAL DEPRIVATION AS A RISK FACTOR FOR INVASIVE MENINGOCOCCAL DISEASE.
Taha MK, Martinon-Torres F, Köllges R, Bonanni P, Safadi MAP, Booy R, Smith V, Garcia S, Bekkat-Berkani R, Abitbol V
Journal:
Expert Rev Vaccines
Publicación independiente
Impact factor
5.217
Q2
COVIDPHY: A TOOL FOR PHYLOGEOGRAPHIC ANALYSIS OF SARS-COV-2 VARIATION
Bello X, Pardo-Seco J, Gómez-Carballa A, Weissensteiner H, Martinón-Torres F, Salas A
Journal:
Environ Res
Publicación independiente
Impact factor
6.498
Q1
CHARACTERISTICS AND MANAGEMENT OF ADOLESCENTS ATTENDING THE ED WITH FEVER: A PROSPECTIVE MULTICENTRE STUDY
Borensztajn D, Hagedoorn NN, Carrol E, von Both U, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie I, Martinon Torres F, Nijman R, Pokorn M, Rivero-Calle I, Tsolia M, Vermont C, Zavadska D, Zenz W, Zachariasse J, Moll HA; PERFORM Consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union.
Journal:
BMJ Open
Publicación independiente
Impact factor
2.692
Q2
EVOLVING STRATEGIES FOR MENINGOCOCCAL VACCINATION IN EUROPE: OVERVIEW AND KEY DETERMINANTS FOR CURRENT AND FUTURE CONSIDERATIONS
Martinón-Torres F, Taha MK, Knuf M, Abbing-Karahagopian V, Pellegrini M, Bekkat-Berkani R, Abitbol V
Journal:
Pathog Glob Health
Publicación independiente
Impact factor
2.894
Q2
IMPROVING EMPIRIC ANTIBIOTIC PRESCRIBING IN PEDIATRIC BLOODSTREAM INFECTIONS: A POTENTIAL APPLICATION OF WEIGHTED-INCIDENCE SYNDROMIC COMBINATION ANTIBIOGRAMS (WISCA)
Cook A, Sharland M, Yau Y; PediBSI Group*, Bielicki J. (Martinón-Torres F)
Journal:
Expert Rev Anti Infect Ther.
Publicación independiente
Impact factor
5.091
Q1
Year:
2022
Doi:
No results found.
Quimioprofilaxis de la enfermedad meningocócica con azitromicina y ciprofloxacino
A. Rodríguez Núñez, F. Martinón Torres, J.M. Martinón Sánchez
Doi:
An Esp Pediatr
Factor de impacto:
Q4
Doi:
Visión pediátrica del transporte medicalizado
J.M.ª Martinón Sánchez, F. Martinón Torres, A. Rodríguez Núñez, M.ªI. Martínez Soto, C. Rial Lobatón, D.G. Jaimovich
Doi:
An Esp Pediatr
Factor de impacto:
Q4
Doi:
Bronquiolitis aguda: evaluación del tratamiento basada en la evidencia
F. Martinón Torres, A. Rodríguez Núñez, J.M. Martinón Sánchez
Doi:
An Esp Pediatr
Factor de impacto:
Q4
Doi:
Advances in Mechanical Ventilation
F. Martinón Torres, A. Rodríguez Núñez, J.M. Martinón Sánchez
Doi:
The New England J. of Medicine
Factor de impacto:
Q1
Doi:
Codificación diagnóstica del síncope en urgencias de pediatría
A. Rodríguez Núñez, J. Eirís Puñal, F. Martinón Torres, J.M. Martinón Sánchez
Doi:
An Esp Pediatr
Factor de impacto:
Q4
Doi:
Retraso de crecimiento intrauterino y polimalformaciones
Bravo Mata M, Pérez Muñuzuri A, Martinón Torres F, Fernández Cebrián S.
Doi:
An Esp Pediatr
Factor de impacto:
Q4
Doi:
Ventilación de alta frecuencia oscilatoria en pacientes pediátricos: aspectos teóricos y prácticos de enfermería
Oreiro Vilacoba MD, Martínez Pérez L, Hervés Rego M, Ageitos Lema A, Martinón-Torres F.
Doi:
Rev. ROL de Enferm.
Factor de impacto:
Doi:
Utilidad de la Capnografía en el paciente crítico con ventilación mecánica
Martinón-Torres F, RodríguezNúñez A, Martinón Sánchez JM.
Doi:
Medicina Intensiva
Factor de impacto:
Q4
Doi:
Evidencias en el tratamiento de la Bronquiolitis
Martinón-Torres F, RodríguezNúñez, Martinón Sánchez JM.
Doi:
An Esp Pediatr
Factor de impacto:
Q4
Doi:
MAPPING GENOME VARIATION OF SARS-COV-2 WORLDWIDE HIGHLIGHTS THE IMPACT OF COVID-19 SUPER-SPREADERS
Alberto Gómez-Carballa, Xabier Bello, Jacobo Pardo-Seco, Federico Martinón-Torres, Antonio Salas
bioRxiv
Factor de impacto:
Q1
Doi:
CLINICAL CHARACTERISTICS OF 58 CHILDREN WITH A PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SARS-COV-2
Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E. Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu Jethro Herberg; Jane C. Burns; Hermione Lyall; Michael Levin; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (Federico Martinón-Torres)
JAMA
Factor de impacto:
Q1
Doi:
RNA-SEQ DATA-MINING ALLOWS THE DISCOVERY OF TWO LONG NON-CODING RNA BIOMARKERS OF VIRAL INFECTION IN HUMANS
Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, María José Currás-Tuala, Sara Pischedda, Sandra Viz-Lasheras, Xabier Bello, Federico Martinón-Torres and Antonio Salas
International J Molecular Sciences
Factor de impacto:
Q1
Doi:
COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION MANAGEMENT IN YOUNG CHILDREN AT THE REGIONAL AND GLOBAL LEVEL: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS OF SUSCEPTIBILITY AND SEVERITY IN ADULT RESPIRATORY SYNCYTIAL VIRUS INFECTIONS.
Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
LOW SENSITIVITY OF BINAXNOW RSV IN INFANTS.
Zuurbier RP, Bont LJ, Langedijk AC, Hamer M, Korsten K, Drysdale SB, Snape MD, Robinson H, Pollard AJ, Martinón-Torres F, Rodríguez-Tenreiro Sánchez C, Gómez-Carballa A, Dacosta-Urbieta AI, Heikkinen T, Cunningham S, van Houten MA, Wildenbeest JG; RESCEU Investigators .
J Infect Dis.
Factor de impacto:
Q1
Doi:
PROTECTING THE MOST VULNERABLE AGE GROUP: A REVIEW OF MENACWY-TT IMMUNOGENICITY AND SAFETY IN INFANTS.
Martinón-Torres F, Serra L, Safadi MAP.
Expert Rev Vaccines
Factor de impacto:
Q2
Doi:
PATHWAY TOWARDS AN IDEAL AND SUSTAINABLE FRAMEWORK AGREEMENT FOR THE PUBLIC PROCUREMENT OF VACCINES IN SPAIN: A MULTI-CRITERIA DECISION ANALYSIS.
Zozaya González N, Alcalá Revilla B, Arrazola Martínez P, Chávarri Bravo JR, Cuesta Esteve I, García Rojas A, Martinón-Torres F, Redondo Margüello E, Rivero Cuadrado A, Tamames Gómez S, Villaseca Carmena J, Hidalgo-Vega A
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
WHOLE-EXOME SEQUENCING FOR THE IDENTIFICATION OF RARE VARIANTS IN PRIMARY IMMUNODEFICIENCY GENES IN CHILDREN WITH SEPSIS - A PROSPECTIVE POPULATION-BASED COHORT STUDY
Alessandro Borghesi, Johannes Trück, Samira Asgari, Vanessa Sancho-Shimizu, Philipp KA Agyeman, Evangelos Bellos, Eric Giannoni, Martin Stocker, Klara M Posfay-Barbe, Ulrich Heininger, Sara Bernhard-Stirnemann, Anita Niederer-Loher, Christian R Kahlert, Giancardlo Natalucci, Christa Relly, Thomas Riedel, Claudia E Kuehni, Christian W. Thorball, Nimisha Chaturvedi, Federico Martinon-Torres, Taco W Kuijpers, Lachlan Coin, Victoria Wright, Jethro Herberg, Michael Levin, Christoph Aebi, Christoph Berger, Jacques Fellay, Luregn J Schlapbach, for the EUCLIDS consortium and the Swiss Paediatric Sepsis Study
Clin Infect Dis
Factor de impacto:
Q1
Doi: